These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 383934)

  • 21. [Efficacy of cefadroxil in acute and chronic bacterial infections of the respiratory tract].
    Nosenzo M; Razzetti A; Delle Piane M; Faravelli B; Suffritti G
    Clin Ter; 1983 Mar; 104(5):383-9. PubMed ID: 6342913
    [No Abstract]   [Full Text] [Related]  

  • 22. Staphylococcal osteomyelitis in children. Success with cephaloridine-cephalexin therapy.
    Walker SH
    Clin Pediatr (Phila); 1973 Feb; 12(2):98-100. PubMed ID: 4686863
    [No Abstract]   [Full Text] [Related]  

  • 23. Zinc Supplementation for One Year Among Children with Cystic Fibrosis Does Not Decrease Pulmonary Infection.
    Sharma G; Lodha R; Shastri S; Saini S; Kapil A; Singla M; Mukherjee A; Jat KR; Kabra M; Kabra SK
    Respir Care; 2016 Jan; 61(1):78-84. PubMed ID: 26443019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leukotriene receptor antagonists in children with cystic fibrosis lung disease : anti-inflammatory and clinical effects.
    Schmitt-Grohé S; Zielen S
    Paediatr Drugs; 2005; 7(6):353-63. PubMed ID: 16356023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cephalexin in internal medicine. Antibacterial treatment in 30 patients, 10 of them with malignant hemopathies, including 6 cases of agranulocytosis (granulocytes 1500/mm3)].
    Mizon JP; Gentit F
    Lille Med; 1975 Jan; 20(1):58-60. PubMed ID: 124374
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical and laboratory studies on S-6437 (a new longacting granule of cephalexin) in pediatric field (author's transl)].
    Kondo K; Kuno K; Koide T; Fukaya K; Jose H
    Jpn J Antibiot; 1977 Sep; 30(9):691-8. PubMed ID: 916190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cephalexin in lower respiratory tract infections.
    Raff MJ
    Postgrad Med J; 1983; 59 Suppl 5():32-9. PubMed ID: 6364088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Absorption, elimination and therapeutic effectiveness of a new antibiotic and mucolytic combination for oral administration].
    Silvia G; Giambrone F; Battaglia E; Romano M
    G Clin Med; 1981 Mar; 62(3):209-27. PubMed ID: 7250579
    [No Abstract]   [Full Text] [Related]  

  • 29. How to use: bacterial cultures in diagnosing lower respiratory tract infections in cystic fibrosis.
    Ahmed B; Bush A; Davies JC
    Arch Dis Child Educ Pract Ed; 2014 Oct; 99(5):181-7. PubMed ID: 24334311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of two dosage schedules in the treatment of streptococcal pharyngitis.
    McLinn SE
    J Int Med Res; 1983; 11(3):145-8. PubMed ID: 6347745
    [No Abstract]   [Full Text] [Related]  

  • 31. Therapy for intercurrent respiratory infections in COLD patients: report on 200 patients.
    Turco P; Pomari C; Zoccatelli O; Trevisan F; Carloni C; Dal Negro RW
    Int J Clin Pharmacol Ther Toxicol; 1983 May; 21(5):260-2. PubMed ID: 6862731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cephalexin dosage in general practice assessed by double-blind trial.
    Johnson SE; Foord RD
    Curr Med Res Opin; 1972; 1(1):37-48. PubMed ID: 4589401
    [No Abstract]   [Full Text] [Related]  

  • 33. Oral cefadroxil in the treatment of bone and joint infections in children and adults.
    Jimenez-Shehab M; Barragan A
    J Antimicrob Chemother; 1982 Sep; 10 Suppl B():149-52. PubMed ID: 6821596
    [No Abstract]   [Full Text] [Related]  

  • 34. A clinical experience with cefadroxil in upper respiratory tract infection.
    Henness DM
    J Antimicrob Chemother; 1982 Sep; 10 Suppl B():125-35. PubMed ID: 6754685
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapeutic efficacy of cefalexin in internal medicine].
    Lechi A; Cecchetin M
    Clin Ter; 1972 Mar; 60(5):439-47. PubMed ID: 5038776
    [No Abstract]   [Full Text] [Related]  

  • 36. [Study of S-6437, sustained release cephalexin, in pediatrics (author's transl)].
    Sato H; Fujii N; Shinnou K; Kojima S; Hirama Y
    Jpn J Antibiot; 1977 Sep; 30(9):684-90. PubMed ID: 916189
    [No Abstract]   [Full Text] [Related]  

  • 37. Cystic fibrosis: Part 1.
    MacLusky I; McLaughlin FJ; Levison H
    Curr Probl Pediatr; 1985 Jun; 15(6):1-49. PubMed ID: 3891236
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical and bacteriological evaluation of minocycline in mucoviscidosis in children].
    Gilly R; Fougerat J
    Poumon Coeur; 1974; 30(5):375-82. PubMed ID: 4469905
    [No Abstract]   [Full Text] [Related]  

  • 39. [Double-blind comparison of L-keflex and cephalexin (Keflex) in dental infections (author's transl)].
    Horii M; Morinaga T; Shimada S; Takeuchi T; Yamanaka H; Nishimura T; Noshi Y; Okada T; Sasaki T; Ikeda S; Takada S; Iizuka O; Kimura J; Sagara S; Inada Y; Nishioka Y; Kimata M
    Jpn J Antibiot; 1980 Nov; 33(11):1194-214. PubMed ID: 7017189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical studies on cefadroxil in pediatrics (author's transl)].
    Terashima I; Nakamura A; Okimoto Y; Kurosaki T; Uehara S
    Jpn J Antibiot; 1981 Jan; 34(1):25-32. PubMed ID: 7017196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.